KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $16.0 million.

  • Bausch Health Companies' Amortization of Deferred Charges rose 2307.69% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.0 million, marking a year-over-year increase of 5636.36%. This contributed to the annual value of $55.0 million for FY2024, which is 1538.46% down from last year.
  • As of Q3 2025, Bausch Health Companies' Amortization of Deferred Charges stood at $16.0 million, which was up 2307.69% from $41.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Amortization of Deferred Charges ranged from a high of $50.0 million in Q2 2022 and a low of $11.0 million during Q1 2023
  • Over the past 5 years, Bausch Health Companies' median Amortization of Deferred Charges value was $14.0 million (recorded in 2022), while the average stood at $18.2 million.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first skyrocketed by 31666.67% in 2022, then tumbled by 7600.0% in 2023.
  • Quarter analysis of 5 years shows Bausch Health Companies' Amortization of Deferred Charges stood at $13.0 million in 2021, then changed by 0.0% to $13.0 million in 2022, then rose by 7.69% to $14.0 million in 2023, then changed by 0.0% to $14.0 million in 2024, then grew by 14.29% to $16.0 million in 2025.
  • Its Amortization of Deferred Charges stands at $16.0 million for Q3 2025, versus $41.0 million for Q2 2025 and $15.0 million for Q1 2025.